1. P668 Measured and modelled data suggest that oral administration of V565, a novel domain antibody to TNF-alpha, could be beneficial in the treatment of IBD. (16th January 2018) Authors: Nurbhai, S; West, M; MacDonald, T; Parkes, G; Irving, P; Vossenkaemper, A; Crowe, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗